Cargando…

Editorial of special column on Drug targets and drug development for Alzheimer's disease

Detalles Bibliográficos
Autores principales: Ding, Wen-Xing, Swerdlow, Russell H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279708/
https://www.ncbi.nlm.nih.gov/pubmed/35847515
http://dx.doi.org/10.1016/j.apsb.2022.03.007
_version_ 1784746459411775488
author Ding, Wen-Xing
Swerdlow, Russell H.
author_facet Ding, Wen-Xing
Swerdlow, Russell H.
author_sort Ding, Wen-Xing
collection PubMed
description
format Online
Article
Text
id pubmed-9279708
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92797082022-07-15 Editorial of special column on Drug targets and drug development for Alzheimer's disease Ding, Wen-Xing Swerdlow, Russell H. Acta Pharm Sin B Editorial Elsevier 2022-04 2022-04-22 /pmc/articles/PMC9279708/ /pubmed/35847515 http://dx.doi.org/10.1016/j.apsb.2022.03.007 Text en © 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
Ding, Wen-Xing
Swerdlow, Russell H.
Editorial of special column on Drug targets and drug development for Alzheimer's disease
title Editorial of special column on Drug targets and drug development for Alzheimer's disease
title_full Editorial of special column on Drug targets and drug development for Alzheimer's disease
title_fullStr Editorial of special column on Drug targets and drug development for Alzheimer's disease
title_full_unstemmed Editorial of special column on Drug targets and drug development for Alzheimer's disease
title_short Editorial of special column on Drug targets and drug development for Alzheimer's disease
title_sort editorial of special column on drug targets and drug development for alzheimer's disease
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279708/
https://www.ncbi.nlm.nih.gov/pubmed/35847515
http://dx.doi.org/10.1016/j.apsb.2022.03.007
work_keys_str_mv AT dingwenxing editorialofspecialcolumnondrugtargetsanddrugdevelopmentforalzheimersdisease
AT swerdlowrussellh editorialofspecialcolumnondrugtargetsanddrugdevelopmentforalzheimersdisease